J&J Petitions FDA to Require ‘Similar’ Names For Biosimilars, Biologics

10.01.2014 - Johnson & Johnson on Wednesday said it submitted a citizen petition asking that U.S. health regulators require copies of biological products to bear names that are similar and not...